Wellington Management Group LLP 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 09:29 am Sale | 2021-12-31 | 13G | REVANCE THERAPEUTICS INC RVNC | Wellington Management Group LLP | 1,104,531 1.540% | -2,293,341 (-67.49%) | Filing |